Bombay HC refuses to hear PIL
seeking uniform rate of Covid-19
The Bombay High Court on Thursday refused to hear a PIL
seeking a direction to the Serum Institute of India and the Bharat
Biotech to sell their COVID-19 vaccines at a uniform rate of Rs
150 (plus GST) per dose.
The public interest litigation (PIL), filed last week by Mumbai-
based advocate Fayzan Khan and three law students, had
challenged the different rates of COVID-19 vaccines for the
Centre and state governments.
The plea was mentioned on Thursday by the petitioner's
advocate, Vivek Shukla, before a division bench of Chief Justice
Dipankar Datta and Justice G S Kulkarni, seeking urgent hearing.
The HC, however, said the petition should have been filed before
the Supreme Court which, while taking up suo motu (on its own)
cognisance of matters pertaining to COVID-19, had said it would
hear all pan-India issues.
"The Supreme Court has said issues that have pan-India effect will
be dealt with by them and pricing is a phenomenon applicable all
over India. We are not entertaining it (PIL) as the apex court has
fairly covered it," the court said. Read More